Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Integrated Patient-Derived Xenograft and Patient-Derived Cell Models Reveal Therapeutic Vulnerabilities Beyond Standard-of-Care Therapy in Endometrial Cancer.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2026
Association between COVID-19 vaccine efficacy and epidemic force of infection.
Journal: NPJ vaccines
Published: September 12, 2025
Neutralizing antibody responses over time in a demographically and clinically diverse cohort of individuals recovered from SARS-CoV-2 acquisition in Africa: A cohort study.
Journal: PLOS global public health
Published: February 04, 2025
Fixed dosing versus weight-based dosing of HIV-1 prophylactic monoclonal antibodies in adults: a post-hoc, cross-protocol pharmacokinetics modelling study.
Journal: EBioMedicine
Published: January 09, 2025
HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines.
Journal: The Journal of infectious diseases
Published: August 13, 2024
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.
Journal: JAMA network open
Published: May 23, 2024
Renal Cell Carcinoma in End-Stage Kidney Disease and the Role of Transplantation.
Journal: Cancers
Published: October 20, 2023
Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine Trial.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: October 18, 2023
Safety and immunogenicity of a polyvalent DNA-protein HIV vaccine with matched Env immunogens delivered as a prime-boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial.
Journal: The lancet. HIV
Published: July 13, 2023
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.
Journal: JAMA network open
Published: July 13, 2023
Last Updated: 09/26/2026